fludarabine has been researched along with Liver Cirrhosis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arase, Y; Hamaki, T; Hayashi, M; Igarashi, M; Ishibashi, T; Kami, M; Kusumi, E; Miyakoshi, S; Morinaga, S; Mutou, Y; Shimamura, K; Takaue, Y | 1 |
Andreani, M; Gaziev, J; Lucarelli, G; Polchi, P; Sodani, P | 1 |
2 other study(ies) available for fludarabine and Liver Cirrhosis
Article | Year |
---|---|
Non-myeloablative hematopoietic stem cell transplantation for the treatment of adult T-cell lymphoma in a patient with advanced hepatic impairment.
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Cyclophosphamide; Hematopoietic Stem Cell Transplantation; Hepatitis B; Humans; Liver Cirrhosis; Lymphoma, T-Cell; Male; Middle Aged; Time Factors; Vidarabine | 2003 |
Bone marrow transplantation in adults with thalassemia: Treatment and long-term follow-up.
Topics: Adolescent; Adult; Azathioprine; Bone Marrow Transplantation; Busulfan; Chelation Therapy; Clinical Protocols; Combined Modality Therapy; Comorbidity; Deferoxamine; Disease-Free Survival; Erythrocyte Transfusion; Erythropoietin; Female; Follow-Up Studies; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Cell Growth Factors; Hemosiderosis; Humans; Hydroxyurea; Immunosuppressive Agents; Iron Chelating Agents; Life Tables; Liver Cirrhosis; Male; Phlebotomy; Postoperative Complications; Survival Analysis; Thalassemia; Transfusion Reaction; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine | 2005 |